Solventum (NYSE:SOLV) Sets New 1-Year High – Should You Buy?

Solventum Corporation (NYSE:SOLV) shares hit a new 52-week high on Tuesday . The stock traded as high as $94.16 and last traded at $92.9160, with a volume of 60086 shares. The stock had previously closed at $91.06.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on SOLV. Weiss Ratings upgraded Solventum from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, August 18th. BTIG Research increased their target price on shares of Solventum from $91.00 to $95.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Wells Fargo & Company cut their price target on shares of Solventum from $83.00 to $70.00 and set an “equal weight” rating on the stock in a report on Wednesday, May 6th. Stifel Nicolaus lifted their price target on shares of Solventum from $90.00 to $100.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Finally, Mizuho set a $113.00 price objective on shares of Solventum in a research note on Thursday, August 6th. Eight analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $91.64.

Solventum Price Performance

The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.74 and a current ratio of 1.02. The business’s fifty day simple moving average is $83.47 and its 200 day simple moving average is $75.78. The stock has a market cap of $15.64 billion, a price-to-earnings ratio of 11.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.61.

Solventum (NYSE:SOLV) last announced its earnings results on Wednesday, August 5th. The company reported $2.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.91 by $0.64. The business had revenue of $2.21 billion for the quarter, compared to analyst estimates of $2.15 billion. Solventum had a return on equity of 25.09% and a net margin of 17.26%.The company’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.69 earnings per share. Solventum has set its FY 2026 guidance at 7.100-7.200 EPS. Research analysts predict that Solventum Corporation will post 7.22 EPS for the current fiscal year.

Institutional Trading of Solventum

Hedge funds have recently made changes to their positions in the stock. MLG Wealth Management DBA Pine Grove Financial Group increased its stake in shares of Solventum by 1.8% in the second quarter. MLG Wealth Management DBA Pine Grove Financial Group now owns 11,084 shares of the company’s stock worth $855,000 after buying an additional 195 shares during the last quarter. Wellington Grp LLC grew its holdings in Solventum by 67.8% during the 2nd quarter. Wellington Grp LLC now owns 11,010 shares of the company’s stock worth $849,000 after acquiring an additional 4,449 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Solventum during the 2nd quarter worth $1,018,000. California State Teachers Retirement System raised its stake in shares of Solventum by 5,434.1% in the 2nd quarter. California State Teachers Retirement System now owns 13,234,928 shares of the company’s stock valued at $1,021,075,000 after purchasing an additional 12,995,776 shares in the last quarter. Finally, Ameritas Advisory Services LLC bought a new position in shares of Solventum during the second quarter worth about $47,000.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.